Econopred Related Published Studies
Well-designed clinical trials related to Econopred (Prednisolone Ophthalmic)
Efficacy of methylprednisolone injected into the masseter muscle following the surgical extraction of impacted lower third molars. [2008.03]
Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study. [2008.02]
Clinical comparison of two topical prednisolone acetate 1% formulations in reducing inflammation after cataract surgery. [2007.10]
High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial. [2007.09]
Anti-inflammatory efficacy of a single posterior subtenon injection of triamcinolone acetonide versus prednisolone acetate 1% eyedrops after pars plana vitrectomy. [2007.09]
Side effects of postoperative administration of methylprednisolone and gentamicin into the posterior sub-Tenon's space. [2007.05]
High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial. [2007.01.31]
Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy. [2007.01]
Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients. [2006.02]
[Efficacy of prednisolone and rimexolone in HLA-B27 positive patients with acute anterior uveitis] [2005.09]
A clinical comparison of two different prednisolone acetate formulations in patients undergoing cataract surgery. [2005.08]
Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study. [2005.08]
Well-designed clinical trials possibly related to Econopred (Prednisolone Ophthalmic)
A single intraoperative sub-tenon's capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery. [2009.07]
Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK. [2009.02]
Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. [2009.01]
Montelukast as an adjunct to oral and inhaled steroid therapy in chronic nasal polyposis. [2008.11]
Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure. [2008.07]
Topical Cyclosporin A in the treatment of acute graft rejection: a randomized controlled trial. [2008.07]
The treatment of giant cell arteritis. [2008.06]
Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification. [2008.03]
Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery. [2008.01]
Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial. [2007.11]
Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty. [2007.08]
Impact of short-term versus longterm topical steroid treatment on 'idiopathic' endothelial cell loss after normal-risk penetrating keratoplasty. [2007.03]
Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes. [2006.10]
Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. [2005.11]
Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy. [2005.09]
Changes in bacterial and fungal ocular flora of clinically normal horses following experimental application of topical antimicrobial or antimicrobial-corticosteroid ophthalmic preparations. [2005.05]
[Ranking of systemic steroids after normal-risk keratoplasty. Results of a randomized prospective study] [2005.05]
Topical FK506 as immunoprophylaxis after allogeneic penetrating normal-risk keratoplasty: a randomized clinical pilot study. [2005.02]
Other research related to Econopred (Prednisolone Ophthalmic)
Quality of life assessment in patients with Graves' disease and progressive infiltrative ophthalmopathy during combined treatment with methylprednisolone and orbital radiotherapy. [2009.05]
Comparative effects of different cosurfactants on sterile prednisolone acetate ocular submicron emulsions stability and release. [2009.03.01]
Inflammatory response after phacoemulsification treated with 0.5% prednisolone acetate or vehicle. [2008.11]
Methylprednisolone fails to preserve retinal ganglion cells and visual function after ocular ischemia in rats. [2008.11]
Effects of high-dose prednisolone on optic nerve head blood flow in patients with acute optic neuritis. [2008.10]
Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery. [2008.08]
Long term results of age-related macular degeneration therapy with prednisolone acetate--special refer to peripheral visual field changes. [2008.06]
Methylprednisolone delivery to the back of the eye using hydrogel iontophoresis. [2008.06]
Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits. [2007.10]
Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis. [2007.09]
Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery. [2007.08.31]
Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren's syndrome. [2007.02]
Intravitreal prednisolone sodium succinate reduces diabetic macular edema without intraocular pressure rise. [2007.01]
Prednisolone neuroprotective therapy in age-related macular degeneration. [2007.01]
Treatment of herpes simplex virus stromal keratitis unresponsive to topical prednisolone 1% with topical cyclosporine 0.05%. [2006.04]
Oral doxycycline, niacinamide and prednisolone used to treat bilateral nodular granulomatous conjunctivitis of the third eyelid in an Australian Kelpie dog. [2005.09]
Other possibly related research studies
Iritis presumed as secondary to disseminated coccidioidomycosis. [2006.11]
[Sympathetic ophthalmia, case report] [2006]
Polymyalgia rheumatica and giant cell arteritis--An ophthalmic emergency. [2006.11]
Ocular manifestations after primary varicella infection. [2006.08]
A case of discoid lupus erythematosus of the eyelid. [2006.05]
Screening for drug-induced spoliation of the hydrogel optic of the AlphaCor artificial cornea. [2006.05]
Sympathetic ophthalmia after injury in the iraq war. [2006.03]
Transient light sensitivity after femtosecond laser flap creation: clinical findings and management. [2006.01]
[Disc neovascularization in a patient with Vogt-Koyanagi-Harada disease and efficacy of steroid pulse therapy] [2006.01]
A case of complete ophthalmoplegia in herpes zoster ophthalmicus. [2005.12]
Corneal ulceration and perforation with ketorolac tromethamine (Acular) use after PRK. [2006.02]
Atypical presentations of orbital cysticercosis. [2005.09]
Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review. [2005.11]
Bilateral optic neuritis in a child following Epstein-Barr virus infection. [2005]
Optic nerve cysticercosis: case report and review of current management. [2005.06]
[A case of delayed facial palsy following gamma knife radiosurgery for intractable trigeminal neuralgia] [2005.09]
[Complete ophthalmoplegia complicating ophthalmic herpes zoster] [2005.05]
Downbeating nystagmus and muscle spasms in a patient with glutamic-acid decarboxylase antibodies. [2005.07]
Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate. [2005.09.14]
Disseminated cysticercosis involving orbit, brain and subcutaneous tissue. [2005.12]
Poor prognosis of visual outcome after visual loss from giant cell arteritis. [2005.06]
HLA-B27-associated uveitis with a chorioretinitis manifestation. [2005.03]
Opinions on risk factors and management of corneal graft rejection in the United kingdom. [2005.04]
Conjunctival lymphoid hyperplasia presenting with bilateral panuveitis. [2005.03]
Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. [2005.01.25]
Topical steroid drops for the treatment of sinus ostia stenosis in the postoperative period. [2006.11]
Bilateral sequential optic neuropathy as the initial manifestation of Sjogren syndrome. [2007.04]
Topical steroids in the management of Churg-Strauss syndrome involving the conjunctiva. [2007.05]
Complete ophthalmoplegia after herpes zoster. [2007.03]
Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. [2007.08.01]
Influence of early cerebrospinal fluid-guided diagnosis and early high-dose corticosteroid therapy on ocular outcomes of Vogt-Koyanagi-Harada disease. [2007.04]
A case of Adamantiades-Behcet disease with ischemic optic neuritis (posterior optic neuropathy). [2007.11]
Optic neuritis associated with chikungunya virus infection in South India. [2007.10]
Steroidal and nonsteroidal antiinflammatory medications can improve photoreceptor survival after laser retinal photocoagulation. [2007.10]
Choroidal and optic nerve infarction in hepatitis C-associated polyarteritis nodosa. [2007.09]
Histopathologic evidence of capecitabine corneal toxicity in dogs. [2007.09]
Repositioning of free cap four days after LASIK. [2007.06]
Intravitreal triamcinolone acetonide injection in CRVO associated with Wegener's granulomatosis. [2007.05]
Unusual eye signs in Wegener's granulomatosis. [2007.06]
Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease. [2007.08]
Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography. [2007.03]
Progressive herpetic linear endotheliitis. [2007.04]
Impact of age, systemic glucocorticoids, and progressive knee arthritis on specific mRNA levels in different areas of the rabbit cornea. [2007.04]
Assessment of inflammation in idiopathic orbital myositis with fat-suppressed T2-weighted magnetic resonance imaging. [2007.04]
Corneal transplant survival after onset of severe endothelial rejection. [2007.09]
The spectrum of Vogt-Koyanagi-Harada disease in South India. [2007.04]
Vitreous injections of pegaptanib sodium triggering allergic reactions. [2007.03]
Ciliochoroidal effusion syndrome associated with posterior scleritis. [2007.01]
Isolated optic neuritis from an identified Gnathostoma spinigerum. [2007.01]
Corneal melt associated with idiopathic dacryoadenitis. [2007.01]
Changes in corneal sensitivity and tear physiology after phacoemulsification. [2008.03]
[Basiliximab following penetrating risk-keratoplasty--a prospective randomized pilot study] [2008.01]
[Long-term results of FK 506 eye drops following corneal transplantation] [2008.01]
Does in vitro susceptibility predict clinical outcome in bacterial keratitis? [2008.03]
[A case of panuveitis with optic disc neovascularization associated with juvenile idiopathic arthritis which progressed during a clinical trial of etanercept] [2007.12]
|
